Kevin Dinnell

Statistics

Publications

Citations

206

H-Index

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Kevin Dinnell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, molecular pharmacology, and pharmacology.

Publications per year

1999–2006

Publications

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent

Kevin Dinnell, Gary G. Chicchi, Madhumeeta J Dhar et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 57 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

3,4-Fused cyclohexyl sulfones as γ-secretase inhibitors

Duncan Shaw, Jonathan D. Best, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

A convenient method for the preparation of aryl cyclopropyl ethers from phenols

Gregory J. Hollingworth, Kevin Dinnell, Laura C. Dickinson et al. · Tetrahedron Letters · 1999 · 20 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Laura C. Cooper, Emma Carlson, José L. Castro et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

1–5 of 6